Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
JPRN |
Last refreshed on:
|
17 October 2023 |
Main ID: |
JPRN-UMIN000013371 |
Date of registration:
|
07/03/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Efficacy of infliximab therapy for arthritis after restorative proctocolectomy in patients with ulcerative colitis
|
Scientific title:
|
Efficacy of infliximab therapy for arthritis after restorative proctocolectomy in patients with ulcerative colitis - Efficacy of infliximab for arthritis after colectomy in ulcerative colitis |
Date of first enrolment:
|
2013/06/05 |
Target sample size:
|
10 |
Recruitment status: |
Complete: follow-up complete |
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012737 |
Study type:
|
Interventional |
Study design:
|
Single arm Non-randomized
|
Phase:
|
Not selected
|
|
Countries of recruitment
|
Japan
| | | | | | | |
Contacts
|
Name:
|
Motoi Uchino |
Address:
|
1-1 Mukogawacho Nishinomiya Hyogo Japan
Japan |
Telephone:
|
0798-45-6111 |
Email:
|
uchino2s@hyo-med.ac.jp |
Affiliation:
|
Hyogo college of medicine Inflammatory bowel disease center |
|
Name:
|
Motoi Uchino |
Address:
|
1-1 Mukogawacho Nishinomiya Hyogo Japan
Japan |
Telephone:
|
0798-45-6111 |
Email:
|
uchino2s@hyo-med.ac.jp |
Affiliation:
|
Hyogo college of medicine Inflammatory bowel disease center |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: Patients with pre-existing malignancy, other infectious disease, heart failure, or infusion reaction for infliximab
Age minimum:
20years-old
Age maximum:
80years-old
Gender:
Male and Female
|
Health Condition(s) or Problem(s) studied
|
ulcerative colitis
|
Intervention(s)
|
infliximab
|
Primary Outcome(s)
|
Evaluate the degree of arthritis according to Bath Ankylosing Spndylitis Disease Activity Index (BASDAI) during treatment with infliximab
|
Source(s) of Monetary Support
|
Hyogo college of medicine
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|